T F Dekoning
- Co-authors
- J. Patrick McGovrenGeorge L. ClarkeRobert C. KellyTanya L. WallaceMartha A. WarpehoskiMark D. PrairieWilliam C. KruegerIlse Gebhard
- Topics
- Cancer therapeutics and mechanisms (5 papers)DNA Repair Mechanisms (3 papers)Bioactive Compounds and Antitumor Agents (2 papers)
- Partner nations
- United StatesNorway
In The Last Decade
T F Dekoning
10 papers receiving 330 citations
Peers
Comparison fields: 5 of 42
- Molecular Biology 262
- Organic Chemistry 134
- Oncology 84
- Toxicology 62
- Pharmacology 61
Countries citing papers authored by T F Dekoning
This map shows the geographic impact of T F Dekoning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T F Dekoning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T F Dekoning more than expected).
Fields of papers citing papers by T F Dekoning
This network shows the impact of papers produced by T F Dekoning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T F Dekoning. The network helps show where T F Dekoning may publish in the future.
Co-authorship network of co-authors of T F Dekoning
This figure shows the co-authorship network connecting the top 25 collaborators of T F Dekoning. A scholar is included among the top collaborators of T F Dekoning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T F Dekoning. T F Dekoning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Combination efficacy with MetMAb and erlotinib in a NSCLC tumor model highlight therapeutic opportunities for c-Met inhibitors in combination with EGFR inhibitors | 9 |
| 2 | 6 | |
| 3 | 7 | |
| 4 | Preclinical antitumor activity of bizelesin in mice. | 18 |
| 5 | Cytotoxicity and antitumor activity of carzelesin, a prodrug cyclopropylpyrroloindole analogue. | 81 |
| 6 | 66 | |
| 7 | 27 | |
| 8 | Relationship between modulation of natural killer cell activity and antitumor activity of bropirimine when used in combination with various types of chemotherapeutic drugs. | 9 |
| 9 | 3 | |
| 10 | 123 |
About T F Dekoning
T F Dekoning is a scholar working on Toxicology, Pharmaceutical Science and Molecular Medicine, having authored 10 papers that have together received 349 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (5 papers), DNA Repair Mechanisms (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). The work is most often cited by research in Toxicology (62 citations), Organic Chemistry (134 citations) and Molecular Biology (262 citations). T F Dekoning has collaborated with scholars based in United States and Norway. Frequent co-authors include J. Patrick McGovren, George L. Clarke, Robert C. Kelly, Tanya L. Wallace, Martha A. Warpehoski, Mark D. Prairie, William C. Krueger, Ilse Gebhard, Li H. Li and Guy E. Padbury. Their work appears in journals such as Cancer Research, Journal of Medicinal Chemistry and Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.